Search Within

Gary Schwartz

Formats
  1. Journal Article (191)
  2. Meeting Abstract (190)
  3. Conference Paper (3)
  4. Book Section (1)
Groups
  1. Department of Medicine (215)
  2. Solid Tumor Oncology Division (205)
  3. Melanoma Disease Management Team (129)
  4. Center for Pancreatic Cancer Research (99)
  5. Gastrointestinal Oncology Service (99)
  6. GSK Faculty (91)

More Groups

People
  1. David Kelsen (79)
  2. Richard Carvajal (61)
  3. Manish Shah (41)
  4. Mark Dickson (40)
  5. Eileen O'Reilly (36)
  6. Monica Motwani (36)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2018 (2)
  4. 2016 (3)
  5. 2015 (5)
  6. 2014 (23)

More Years

Publications
  1. Journal of Clinical Oncology (103)
  2. Cancer Research (42)
  3. Clinical Cancer Research (39)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (30)
  5. Annals of Oncology (12)
  6. Cancer (12)

More Publications

Publishers
  1. American Association for Cancer Research (121)
  2. American Society of Clinical Oncology (105)
  3. Elsevier Inc. (20)
  4. Springer (20)
  5. Oxford University Press (16)
  6. Wiley Blackwell (15)

More Publishers

Results (385)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: Preclinical investigations and results of a phase I dose-escalation clinical trial
    Journal Article

    Luke, J. J.; D'adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Maki, R. G.; de Stanchina, E.; Musi, E.; Singer, S.; Schwartz, G. K.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • A population pharmacokinetic (Pk) pharmacodynamic (Pd) model describing the time course of platelet changes in advanced solid tumor patients treated with Pd 0332991
    Meeting Abstract

    Shaik, M.; Ruiz-Garcia, A.; O'Dwyer, P.; LoRusso, P. M.; Schwartz, G.; Randolph, S.
    Clinical Pharmacology & Therapeutics (2012)

    Fulltext@MSK | Save
  • The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent
    Journal Article

    Nair, J. S.; Ho, A. L.; Schwartz, G. K.
    Cell Cycle (2012)

    Fulltext@MSK | Save
  • Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer
    Journal Article

    Flaherty, K. T.; LoRusso, P. M.; DeMichele, A.; Abramson, V. G.; Courtney, R.; Randolph, S. S.; Shaik, M. N.; Wilner, K. D.; O'Dwyer, P. J.; Schwartz, G. K.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial
    Meeting Abstract

    Schwartz, G. K.; Maki, R. G.; Ratain, M. J.; Undevia, S. D.; Jones, R. L.; Rudin, C. M.; Siu, L. L.; Brockstein, B.; Khayat, D.; Gil, T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Brivanib (BMS-582664) in advanced solid tumors (AST): Results of a phase II randomized discontinuation trial (RDT)
    Meeting Abstract

    Ratain, M. J.; Schwartz, G. K.; Oza, A. M.; Rudin, C. M.; Kaye, S. B.; De Jonge, M. J.; Khayat, D.; Awada, A.; Sawyer, M. B.; Obel, J. C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Results of a study of the oral inhibitor PTC299 on tumor VEGF synthesis
    Meeting Abstract

    Luke, J. J.; Callahan, L. A.; Darby, C. H.; Winkelman, M. J.; Barth, J.; Elfring, G. L.; Ogden, A.; Schwartz, G. K.; Gounder, M. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I, open-label, dose-escalation study of AZD7762 in combination with irinotecan (irino) in patients (pts) with advanced solid tumors
    Meeting Abstract

    Ho, A. L.; Bendell, J. C.; Cleary, J. M.; Schwartz, G. K.; Burris, H. A.; Oakes, P.; Agbo, F.; Barker, P. N.; Senderowicz, A. M.; Shapiro, G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors
    Meeting Abstract

    Dickson, M. A.; LoRusso, P.; Sausville, E. A.; Rao, N.; Kobayashi, E.; Kurman, M. R.; Akinaga, S.; Schwartz, G. K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save